Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Atrion Dividend Announcement
• Atrion announced a quarterly dividend of $2.20 per ordinary share which will be made payable on 2024-06-28. Ex dividend date: 2024-06-14
• Atrion annual dividend for 2024 was $4.40
• Atrion annual dividend for 2023 was $8.70
• Atrion's trailing twelve-month (TTM) dividend yield is 1.44%
• Atrion's payout ratio for the trailing twelve months (TTM) is 123.33%
• Atrion's dividend growth over the last five years (2018-2023) was 11.27% year
• Atrion's dividend growth over the last ten years (2013-2023) was 13.74% year
Atrion Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-14 | $2.20 | quarterly | 2024-06-28 |
2024-03-14 | $2.20 | quarterly | 2024-03-29 |
2023-11-30 | $2.20 | quarterly | 2023-12-15 |
2023-09-14 | $2.20 | quarterly | 2023-09-29 |
2023-06-14 | $2.15 | quarterly | 2023-06-30 |
2023-03-14 | $2.15 | quarterly | 2023-03-31 |
2022-11-30 | $2.15 | quarterly | 2022-12-15 |
2022-09-14 | $2.15 | quarterly | 2022-09-30 |
2022-06-14 | $1.95 | quarterly | 2022-06-30 |
2022-03-14 | $1.95 | quarterly | 2022-03-31 |
2021-11-30 | $1.95 | quarterly | 2021-12-15 |
2021-09-14 | $1.95 | quarterly | 2021-09-30 |
2021-06-14 | $1.75 | quarterly | 2021-06-30 |
2021-03-12 | $1.75 | quarterly | 2021-03-31 |
2020-11-30 | $1.75 | quarterly | 2020-12-15 |
2020-09-14 | $1.75 | quarterly | 2020-09-30 |
2020-06-12 | $1.55 | quarterly | 2020-06-30 |
2020-03-13 | $1.55 | quarterly | 2020-03-31 |
2019-11-29 | $1.55 | quarterly | 2019-12-16 |
2019-09-13 | $1.55 | quarterly | 2019-09-30 |
2019-06-13 | $1.35 | quarterly | 2019-06-28 |
2019-03-14 | $1.35 | quarterly | 2019-03-29 |
2018-11-30 | $1.35 | quarterly | 2018-12-17 |
2018-09-13 | $1.35 | quarterly | 2018-09-28 |
2018-06-14 | $1.20 | quarterly | 2018-06-29 |
2018-03-14 | $1.20 | quarterly | 2018-03-30 |
2017-11-30 | $1.20 | quarterly | 2017-12-15 |
2017-09-14 | $1.20 | quarterly | 2017-09-29 |
2017-06-13 | $1.05 | quarterly | 2017-06-30 |
2017-03-13 | $1.05 | quarterly | 2017-03-31 |
2016-11-29 | $1.05 | quarterly | 2016-12-15 |
2016-09-13 | $1.05 | quarterly | 2016-09-30 |
2016-06-13 | $0.90 | quarterly | 2016-06-30 |
2016-03-11 | $0.90 | quarterly | 2016-03-31 |
2015-11-27 | $0.90 | quarterly | 2015-12-15 |
2015-09-11 | $0.90 | quarterly | 2015-09-30 |
2015-06-11 | $0.75 | quarterly | 2015-06-30 |
2015-03-13 | $0.75 | quarterly | 2015-03-31 |
2014-11-26 | $0.75 | quarterly | 2014-12-15 |
2014-09-11 | $0.75 | quarterly | 2014-09-30 |
2014-06-12 | $0.64 | quarterly | 2014-06-30 |
2014-03-13 | $0.64 | quarterly | 2014-03-31 |
2013-11-27 | $0.64 | quarterly | 2013-12-16 |
2013-09-11 | $0.64 | quarterly | 2013-09-30 |
2013-06-12 | $0.56 | quarterly | 2013-06-28 |
2013-03-13 | $0.56 | quarterly | 2013-03-29 |
Atrion Dividend per year
Atrion Dividend growth
Atrion Dividend Yield
Atrion current trailing twelve-month (TTM) dividend yield is 1.44%. Interested in purchasing Atrion stock? Use our calculator to estimate your expected dividend yield:
Atrion Financial Ratios
Atrion Dividend FAQ
Other factors to consider when evaluating Atrion as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Atrion stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Atrion's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Atrion publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Atrion distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Atrion are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Atrion sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Atrion distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Atrion declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Atrion's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Atrion's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.